A Georgia lawmaker is trying to pump the brakes on a longtime police practice that generates millions for small cities off ...

TARPON SPRINGS —The Arbor Day Foundation has named Tarpon Springs a 2024 Tree City USA in honor of its commitment to plant, grow, and maintain trees to benefit its community.

In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands against the other stocks. Jim Cramer, the host of Mad Money, recently expressed his concerns ...

The board of directors of the Company (the "Board of Directors") hereby informs the shareholders of the Funds (the "Shareholders") that MSCI Limited, in its capacity as index administrator of the ...

Nisa Investment Advisors LLC grew its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 23.1% in the fourth quarter, according to its most recent filing with the SEC.

Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Sell rating on Sarepta Therapeutics (SRPT – Research Report). The associated price target remains the same with $75.00.

Sarepta Therapeutics (NASDAQ:SRPT), a biotechnology company specializing in precision genetic medicines for rare diseases with a market capitalization of $11.2 billion, stands at a critical ...

Sarepta's third-quarter results for 2024 exceeded expectations, with total revenue reaching approximately $430 million, surpassing the consensus estimate of $400 million. The company's trailing twelve ...

Shares of Sarepta (SRPT) are down this morning, potentially due to the latest FDA Adverse Event Reporting System update on Elevidys, which included a patient death from November in a patient who ...